BIO-EUROPE SIDE EVENT – MVA Microbiome Network meeting

    Welcome to BIO-Europe side event – Microbiome
    – in collaboration with Medicon Valley Alliance Microbiome Network

    BIO-Europe is coming to Copenhagen 5th – 7th of November this year. This is a unique opportunity to showcase regional life science strongholds and reach out to the many international guests before they travel back.  
    In order to seize this opportunity, Medicon Valley Alliance (MVA), Invest in Skåne, Copenhagen Capacity, and MVA Microbiome Network have joined forces and decided to bring together international and regional preclinical and clinical researchers, medtech, biotech and the pharmaceutical industry to present and to discuss new exciting innovations in the field of Microbiome. 

    Medicon Valley Alliance, Copenhagen Capacity, and Invest in Skåne are happy to invite you to the BIO-Europe Side Event – Microbiome:

    Date: 8th of November, 2018
    Time: 08.30- 13.00
    Hosts: Medicon Valley Alliance, Copenhagen Capacity, Invest in Skåne
    Venue: Medicon Valley Alliance, Auditorium, Edvard Thomsens Vej 14, 2300 Copenhagen S

    Sign up

    The meeting will be a pitch-event where we selected regional academic and industrial organizations are given the opportunity to pitch their projects/products/business concept. In addition, we have plenty of networking time to allow all international and regional meeting participants to interact with each other.

    Don’t miss this opportunity to become updated about regional microbiome activities as well as to network with regional and international stakeholders!  

    The MVA Microbiome Network
    Joining the network is free of charge and is limited to Medicon Valley Alliance members. However, non-member organizations and companies are welcome to attend one network event to evaluate if being part of the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically able you to join the microbiome network.

    Moderator: Eric de La Fortelle, Venture Partner, Seventure Partners, Paris, France

    08.30-09.00 Registration, networking and breakfast
    09.00-09.05 Welcome
    Petter Hartman, CEO, Medicon Valley Alliance
    09.05-09.10 Sponsor of the event
    Nadine Eckert-Boulet Bravo, European Patent Attorney, HØIBERG P/S
    09.10-09.25 Keynote Speaker:
    Setting the scene: Trends in the Microbiome area

    Agam Sheth, PhD, Director, Business Development and Licensing, Merck Research Laboratories, Merck & Co., Inc., USA


    Learnings from Investing in 20 Microbiome companies

    Eric de La Fortelle, Venture Partner, Seventure Partners, France

    Pitches (5-minute academic/corporate presentations)

    Pitch 1: Ferring Exploring the Secrets of the Microbiome
    Torsten Reinheimer, Principal Scientist, Ferring Pharmaceuticals A/S

    Pitch 2: Gut microbiota and bipolar disorder: a potential link?
    Klara Coello, MD, PhD, Psychiatric Center Copenhagen, Rigshospitalet, and Faculty of Health and Medical Sciences, University of Copenhagen

    Pitch 3: Microbial therapy targeting the gut microbiome and beyond  –   a translational success story
    Shahram Lavasani, CEO, ImmuneBiotech AB

    Pitch 4: Modulating the atopic dermatitis skin microbiome
    Morten Sommer; CEO, Union Therapeutics A/S

    Pitch 5: Gut microbiota and Alzheimer’s disease: dietary modulation of the gut-brain axis
    Frida Fåk Hållenius, Associate Professor, Lund University

    Pitch 6: Custom tailored microbiome analysis
    Henrik Bjørn Nielsen, CSO, Clinical-Microbiomics A/S

    Pitch 7: Gut microbiota and celiac disease
    Elin Oscarsson, PhD Student, Lund University

    Networking and coffee

    Pitch 8: Delivering on the Promise of Microbiome based Probiotics
    Adam Baker, Head of Discovery, Microbiome and Human Health, Chr-Hansen A/S

    Pitch 9: Probi – First in probiotics
    Linda Neckmar, VP EMEA & APAC, Probi AB

    Pitch 10: Impact of ingested bacteria on gut microbiota and immune functions
    Åsa Håkansson, Senior lecturer, Lund University

    Pitch 11: A novel and antibiotic-free treatment of vaginal infections targeting both bacteria and fungi
    Annette Säfholm, CEO, Gedea Biotech AB

    Pitch 12: Bioneer – your innovative partner in microbiome R&D
    Kim Holmstrøm, R&D Manager, Bioneer A/S

    Pitch 13: Identifying novel antimicrobials from human gut microbiota
    Thiyagarajan Gnanasekaran, PostDoc, University of Copenhagen

    Pitch 14: Optimizing gut health with personalized nutrition
    Kristofer Cook, CEO, Carbiotix AB

    11.55-12.00 Wrap up
    Eric de La Fortelle, Venture Partner, Seventure Partners, Paris, France
    12.00-13.00 Mingle lunch & 1-1-meetings

    Deadline for registration is 5th of November, 2018.

    For more information please contact Senior Project Manager Helen Pettersson: hp [at]


    In collaboration with
    Steering group, Medicon Valley Alliance Microbiome Network: